Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Discussing new research with healthcare providers ensures you receive current guidance
Archived from the original on 12 August 2025
All of the injured rats that received BPC 157 exhibited consistent clinical improvement, increasingly better motor function of the tail, no autotomy, and resolved spasticity by day 15
CJC-1295 / Ipamorelin What It Is: A synthetic growth-hormone-releasing peptide stack combining CJC-1295, a modified growth hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective ghrelin-receptor agonist (growth hormone secretagogue)
Both individual peptides appear in Health Canada's public advisories on unauthorized injectable peptide products
